:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	Ling Xue, Guangda Ma, Nick Holford, Qiong Qin, Yinglong Ding, Jacqueline A. Hannam, Xiaoliang Ding, Hongyou Fan, Zhenchun Ji, Biwen Yang, Han Shen, Zhenya Shen, Liyan Miao
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Clinical Pharmacology & Therapeutics
Online Access:	https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.3207
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Letter: The Risk and Outcomes of Gastrointestinal Bleeding in Patients Using Warfarin or Direct Oral Anticoagulants
by: Jiaqi Shen, et al.
Published: (2026)

Clinical Trial: Immunogenicity of Double‐Dose Versus Standard‐Dose of Hepatitis B Virus Vaccine in Inflammatory Bowel Disease
by: Anupam Kumar Singh, et al.
Published: (2025)

Editorial: Managing the Moving Target—Dose Adjustments in Inflammatory Bowel Disease
by: Nicholas Clark, et al.
Published: (2025)

Research Communication: The Risk and Outcomes of Gastrointestinal Bleeding in Patients Using Warfarin or Direct Oral Anticoagulants
by: Lauren Holtslander, et al.
Published: (2025)

Microbiome‐Informed Dosing: Exploring Gut Microbial Communities Impact on Mycophenolate Enterohepatic Circulation and Therapeutic Target Achievement
by: Abdelrahman Saqr, et al.
Published: (2025)

Optimizing Maternal and Fetal Antibody Exposure and Dosing Regimens During Pregnancy Using a Physiologically Based Pharmacokinetic Model
by: Miramar Sami Kardouh, et al.
Published: (2025)

Model‐Informed Precision Dosing Using Machine Learning for Levothyroxine in General Practice: Development, Validation and Clinical Simulation Trial
by: Jules M. Janssen Daalen, et al.
Published: (2024)

Post hoc Population Standardization of Trial Emulation Studies in Claims Data: An RCT ‐ DUPLICATE Analysis
by: Phyo Than Htoo, et al.
Published: (2026)

Beyond Population‐Level Targets for Drug Concentrations: Precision Dosing Needs Individual‐Level Targets that Include Superior Biomarkers of Drug Responses
by: Thomas M. Polasek, et al.
Published: (2024)

Clinical Trial: Dose‐Finding Study of Linaprazan Glurate, A Novel Potassium‐Competitive Acid Blocker, Versus Lansoprazole for the Treatment of Erosive Oesophagitis
by: Prateek Sharma, et al.
Published: (2025)

Letter: Incidence and Predictors of Major Gastrointestinal Bleeding in Patients on Aspirin, Low‐Dose Rivaroxaban or the Combination: Secondary Analysis of the COMPASS Randomised Controlled Trial
by: Yu Yang, et al.
Published: (2024)

Letter: Incidence and Predictors of Major Gastrointestinal Bleeding in Patients on Aspirin, Low‐Dose Rivaroxaban or the Combination: Secondary Analysis of the COMPASS Randomised Controlled Trial. Authors' Reply
by: Nauzer Forbes, et al.
Published: (2024)

Verekitug, a Novel Antibody Antagonist to the TSLP Receptor in Adults with Asthma: A 32‐Week Randomized Phase 1b Multiple Ascending‐Dose Trial
by: Dave Singh, et al.
Published: (2025)

Bringing Trial Activities to Participants—The Trials@Home RADIAL Proof‐of‐Concept Trial Investigating Decentralization of Trials
by: Mira G.P. Zuidgeest, et al.
Published: (2025)

Assessment of Dosing Strategies for Pediatric Drug Products
by: Zachary L. Taylor, et al.
Published: (2024)

Letter: Steroid Tapering—Is Shorter Duration Better?
by: Juntao Lu, et al.
Published: (2026)

Correction to “Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single‐Patient Data Meta‐Analysis in More Than 15,000 Individuals”
Published: (2024)

Letter: Ulcerative proctitis—A step towards addressing the knowledge gap, and a call for greater detail, in trial data
by: John David Chetwood, et al.
Published: (2024)

Operationalizing Decentralized Clinical Trials: Technology Insights from the Trials@Home RADIAL Proof‐of‐Concept Trial
by: Sten Hanke, et al.
Published: (2025)

Longitudinal Tumor Size and Survival Modeling for Exposure–Response Analysis of Drugs with Frequent Dose Reductions: Dose Justification of Abemaciclib in Patients with Metastatic Breast Cancer
by: Emmanuel Chigutsa, et al.
Published: (2026)

Moving the Needle for Oncology Dose Optimization: A Call for Action
by: Karthik Venkatakrishnan, et al.
Published: (2024)

Dose Optimization Informed by PBPK Modeling: State‐of‐the Art and Future
by: Karen Rowland Yeo, et al.
Published: (2024)

Dosing and Exposure of Vancomycin With Continuous Infusion: A Retrospective Study
by: Judith Y. M. N. Derijks‐Engwegen, et al.
Published: (2024)

Clinical Safety of Extended Interval Dosing of Nivolumab in Patients with Melanoma
by: Ruben Malmberg, et al.
Published: (2025)

Letter: Lubiprostone Treatment for MASLD—Gender Imbalance and Blinding Considerations
by: Jiru Li, et al.
Published: (2025)

Model‐Informed Precision Dosing of Busulfan for Children and Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Critical Evaluation of Current PK Models and Dose Recommendations
by: Rashudy F. Mahomedradja, et al.
Published: (2025)

Editorial: The prevalence and outcomes of perianal Crohn's disease across treatment eras
by: Daniel Tassone, et al.
Published: (2024)

Model‐Based Benefit/Risk Analysis for the Copanlisib Intermittent Dosing Regimen
by: Peter N. Morcos, et al.
Published: (2024)

Getting the Dose Right in Drug Development for Rare Diseases: Barriers and Enablers
by: Mariam A. Ahmed, et al.
Published: (2024)

Editorial: UDCA Dosing in PBC – Between Guideline Adherence and Clinical Reality
by: Helena Hernández‐Évole, et al.
Published: (2026)

Optimizing Body Size‐Based Dosing Approaches for Antibody–Drug Conjugates
by: Andrew B. SyBing, et al.
Published: (2025)

Infrequent Resolution of Vaso‐Occlusive Crises in Routine Clinical Care Among Patients Mimicking the Exa‐Cel Trial Population: A Cohort Study of Medicaid Enrollees
by: Mufaddal Mahesri, et al.
Published: (2024)

Regulatory Interactions and Learnings— RADIAL the Trials@Home Proof‐of‐Concept Trial on Decentralization
by: Helga Gardarsdottir, et al.
Published: (2025)

Letter: Positivity of High‐Sensitivity HBsAg Test Was Significantly Associated With Poor Prognosis in Patients With Non‐HBV‐Related HCC
by: Xiaosong Li, et al.
Published: (2024)

Letter: The Essential Role of Social Workers in Reducing Socioeconomic Disparities in Chronic Liver Disease
by: Qiong Yi, et al.
Published: (2024)

Dosing Strategies and Quantitative Clinical Pharmacology for Bispecific T‐Cell Engagers Development in Oncology
by: Mohamed Elmeliegy, et al.
Published: (2024)

Real‐World Edoxaban Concentrations in Older Patients Receiving Reduced‐Dose Regimens
by: Sung‐Chun Tang, et al.
Published: (2025)

Crossing the Chasm: How to Approach Translational Pharmacokinetic–Pharmacodynamic Modeling of Phage Dosing
by: Gauri G. Rao, et al.
Published: (2024)

The Drug Titration Paradox Updated and Reinterpreted: With Perfect Titration, Dose and Effect Will Be Uncorrelated
by: Elie Sarraf, et al.
Published: (2025)

Pharmacokinetics and Exposure–Response Analyses to Support Dose Selection of Upadacitinib in Crohn's Disease
by: Sumit Bhatnagar, et al.
Published: (2024)